-

Mevion Selected to Provide Proton Therapy System in Córdoba, Spain

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems is delighted to be selected to participate in the proton therapy initiative between the city of Córdoba in Andalusia, Spain, the Ministry of Health and Families of Andalusia, and the University of Córdoba to establish an alliance with the Andalusian Health Service and the University Institution. In the initiative, Mevion will provide its revolutionary MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning which will be made available to Andalusian Health Service patients.

Proton therapy is an advanced form of radiation therapy that reduces unnecessary radiation dose to healthy tissue and prevents complications and secondary cancers. Mevion’s leading HYPERSCAN Pencil Beam Scanning technology further enhances these benefits with a faster and sharper dose delivery that can be collimated layer-by-layer to provide a more precise and conformal dose to the tumor.

The new state-of-the-art proton therapy center that will benefit patients in southern Spain and surrounding regions will be located in the Córdoba Technology Park next to the University of Córdoba. This initiative will also foster the creation of a Research, Development, and Innovation collaboration with the University of Córdoba and other Andalusian public universities.

“The development of this project represents a milestone for the future since it places the city in the first row of development in innovation and technological development linked to the health field,” said José María Bellido, mayor of Córdoba.

“We are honored to be selected for this opportunity to provide proton therapy to patients and clinicians in southern Spain and look forward to collaborating closely with the City of Córdoba, the University of Córdoba and the Ministry of Health,” said James Meng, Ph.D. president of Mevion Medical Systems.

To learn more about the proton therapy initiative in Córdoba, Spain, please see the University of Cordoba's announcement.

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com.

Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical

Contacts

Melanie Benton
Mevion Medical Systems
Mbenton@mevion.com 1-978-540-1551

More News From Mevion Medical Systems

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the global leader in compact proton therapy, today announced that it has been selected to deliver the MEVION S250-FIT Proton Therapy System™ to Istituto Nazionale Tumori IRCCS Fondazione G. Pascale in Naples. The award, made following a competitive European tender, will establish the first proton therapy center in Southern Italy, significantly expanding access to advanced radiation therapy for patients across the region and reducing the...

Mevion to Bring MEVION S250-FIT™ Proton Therapy System to Multidisciplinary Care Setting

BOSTON--(BUSINESS WIRE)--Mevion Medical Systems, a leader in compact proton therapy solutions, today announced that Dana-Farber Cancer Institute will install the MEVION S250-FIT Proton Therapy System™ at its Longwood Medical Area campus. The installation will integrate proton therapy directly into Dana-Farber's multidisciplinary care environment, including pediatric care delivered through the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. “Proton therapy is a critical tool in...

Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 2026

LITTLETON, Mass.--(BUSINESS WIRE)--Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatm...
Back to Newsroom